Enrolling by invitationPhase 2NCT06148311
Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia
Studying Familial dysautonomia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- Alejandra Gonzalez-Duarte, MDNYU Langone Health, NYU Dysautonomia Center
- Intervention
- Matching placebo(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 16-80 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- NYU Langone Health, New York, New York, United States
Collaborators
Food and Drug Administration (FDA)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06148311 on ClinicalTrials.govOther trials for Familial dysautonomia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06863207Autonomic Reactivity and Personalized NeurostimulationMedical College of Wisconsin
- ACTIVE NOT RECRUITINGPHASE2NCT06128356Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial DysautonomiaNYU Langone Health
- RECRUITINGNCT03920774The Natural History of Familial DysautonomiaNYU Langone Health